← FDA DRUG APPROVALS

FDA ANDA · ANDA085266

DI-ATRO

Sponsor: MD PHARM

APPLICATION
ANDA085266
TYPE
ANDA
ORIGINAL APPROVAL
1977-04-18
LATEST ACTION
1992-03-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DI-ATRODiscontinued
ATROPINE SULFATE 0.025MG, DIPHENOXYLATE HYDROCHLORIDE 2.5MG · TABLET · ORAL

Approval history

1992-03-30Labeling · Supplement 71AP
1989-04-05Labeling · Supplement 70AP
1988-10-18Labeling · Supplement 69AP
1988-05-25Labeling · Supplement 68AP
1977-04-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →